A new side effect of inhaled nitric oxide in neonates and infants with pulmonary hypertension: Functional impairment of the neutrophil respiratory burst

Intensive Care Medicine

Volumn 22, Issue 3, 1996, Pages 252-258

  Gessler, P ^a   Nebe, T ^a   Birle, A ^a   Mueller, W ^a   Kachel, W ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Inhaled nitric oxide; Pulmonary hypertension; Respiratory burst of neutrophils

Indexed keywords

FORMYLMETHIONYLLEUCYLPHENYLALANINE; NITRIC OXIDE; SUPEROXIDE;

ARTICLE; CLINICAL ARTICLE; ESCHERICHIA COLI; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; INFANT; INHALATIONAL DRUG ADMINISTRATION; NEUTROPHIL; NEWBORN; PULMONARY HYPERTENSION; RESPIRATORY BURST; SIDE EFFECT; TIME;

ADMINISTRATION, INHALATION; FLOW CYTOMETRY; HUMANS; HYPERTENSION, PULMONARY; INFANT; INFANT, NEWBORN; NEUTROPHIL ACTIVATION; NITRIC OXIDE; PROSPECTIVE STUDIES; RESPIRATORY BURST; SUPEROXIDES; TIME FACTORS;

EID: 0029992013     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01712246     Document Type: Article

References (36)

1. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J (1991) Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 338: 1173-1174
2. Rossaint R, Falke KJ, López F, Slama K, Pison V, Zapol WM (1993) Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 328: 339-405
3. Journois D, Pouard P, Mauriat P, Malhere T, Vouhe P, Safran D (1994) Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects. J Thorac Cardiovasc Surg 107: 1129-1135
4. Zayek M, Wild L, Roberts JD, Morin FC (1993) Effect of nitric oxide on the survival rate and incidence of lung injury in newborn lambs with persistent pulmonary hypertension. J Pediatr 123: 947-952
5. Roberts JD, Polaner DM, Lang P, Zapol WM (1992) Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340: 818-819
6. Kinsella JP, Neish SR, Shatter E, Abman SH (1992) Low dose inhalational nitric oxide therapy in persistent pulmonary hypertension of the newborn. Lancet 340: 819-820
7. Levin DL, Heymann MA, Kitterman JA, Gregory GA, Phibbs RH, Rudolph AM (1976) Persistent pulmonary hypertension of the newborn. J Pediatr 89: 626-633
8. Moncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329: 2002-2012
9. Gruetter CA, Gruetter DY, Lyon JE, Kadowitz PJ, Ignarro LJ (1981) Relationship between cyclic guanosine 3′: 5′-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrale, nitroprusside, nitrate, and nitric oxide: effects of methylene blue and methemoglobin. J Pharmacol Exp Ther 219: 181-186
10. Naeda N, Laraizumi K, Kon K, et al. (1987) A kinetic study on function impairment of nitric oxide exposed rat erythrocytes. Environ Health Perspect 73: 171-177
11. Mellion BT, Ignarro LJ, Ohlstein EH, Pontecorvo FG, Hyman AL, Kadowitz PJ (1981) Evidence for the inhibitory role of guanosine 3′5′-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 57: 946-955
12. Kubes P, Suzuki M, Granger DN (1991) Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88: 4651-4655
13. Clancy RM, Leszczynska-Piziak J, Abramson SB (1992) Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest 90: 1116-1121
14. Cummings JJ, D'Eugenio DB, Gross SJ (1989) A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med 320: 1505-1510
15. Harkavy KL, Scanlon JW, Chowdhry PK, Grylack LJ (1989) Dexamethasone therapy for chronic lung disease in ventilator- and oxygen-dependent infants: a controlled trial. J Pediatr 115: 979-983
16. Bass DA, Parce JW, Dechatelet LR, Szejda P, Seed MC, Thomas M (1983) Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol 130: 1910-1917
17. Smith JA, Weidemann MJ (1993) Further characterization of the neutrophil oxidative burst by flow cytometry. J Immunol Methods 162: 261-268
18. Theodorsson-Norheim E (1986) Kruskal-Wallis test: BASIC computer program to perform nonparametric oneway analysis of variance and multiple comparisons on ranks of several independent samples. Comput Methods Programs Biomed 23: 57-62
19. Peltola H, Jaakola M (1988) C-reactive protein in early detection of bacteremic versus viral infections in immunocompetent compromised children. J Pediatr 113: 641-646
20. Pourcyrous M, Bada HS, Korones SB, Baselski V, Wong SP (1993) Significance of serial C-reactive protein responses in neonatal infection and other disorders. Pediatrics 92: 431-435
21. Kinsella JP, Abman SH (1993) Inhalational nitric oxide therapy for persistent pulmonary hypertension of the newborn. Pediatrics 91: 997-998
22. Bone RC (1993) A new therapy for the adult respiratory distress syndrome. N Engl J Med 328: 431-432
23. Finer NN, Etches PC, Kamstra B, Tierney AJ, Peliowski A, Ryan CA (1994) Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: dose response. J Pediatr 124: 302-308
24. Babior BM (1984) The respiratory burst of phagocytes. J Clin Invest 73: 599-601
25. Dewald B, Baggiolini M, Curnutte JT, Babior BM (1979) Subcellular localization of the superoxide-forming enzyme in human neutrophils. J Clin Invest 63: 21-29
26. Tauber AI (1987) Protein kinase C and the activation of the human neutrophil NADPH-oxidase. Blood 69: 711-720
27. Combadiere C, Benna JE, Pedruzzi E, Hakim J, Penanin A (1993) Stimulation of the human neutrophil respiratory burst by formyl peptides is primed by a protein kinase inhibitor, stauros-porine. Blood 82: 2890-2898
28. Curnutte JT, Whitten DM, Babior BM (1974) Defective superoxide production by granulocyles from patients with chronic granulomatous disease. N Engl J Med 290: 593-597
29. Bass DA, Olbrantz P, Szejda P, Seeds MC, McCall CH (1986) Surpopulations of neutrophils with increased oxidative product formation in blood of patients with infection. J Immunol 136: 860-866
30. Elbim C, Chollet-Martin S, Bailly S, Hakim J, Gougerot-Pocidalo MA (1993) Priming of polymorphonuclear neutrophils by tumor necrosis factor α in whole blood: identification of two polymorphonuclear neutrophil sub-populations in response to formyl-peptides. Blood 82: 633-640
31. Balazovich KJ, Almeida HI, Boxer LA (1991) Recombinant human G-CSF and GM-CSF prime human neutrophils for superoxide production through different signal transduction mechanisms. J Lab Clin Med 118: 576-584
32. Sullivan GW, Carper HT, Mandell GL (1993) The effect of three human recombinant hematopoietic growth factors (granulocyte-maerophage colony-stimulating factor, granulocyte colony-stimulating factor, and interleukin-3) on phagocyte oxidative activity. Blood 81: 1863-1870
33. Nielson CP, Bayer C, Hodson S, hadjokas N (1992) Regulation of the respiratory burst by cyclic 3′,5′-AMP, an association with inhibition of arachidonic acid release. J Immunol 149: 4036-4040
34. Moncada S (1992) The L-arginine: nitric oxide pathway. Acta Physiol Scand 145: 201-227
35. Ialenti A, Ianaro A, Moncada S, Di Rosa M (1992) Modulation of acute inflammation by endogenous nitric oxide. Eur J Pharmacol 211: 177-182
36. Nathan CF (1987) Neutrophil activation on biological surfaces: massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J Clin Invest 80: 1550-1556